Genopathy
Gene-Disorder Association · Article
Gene
ALDH2
Aldehyde Dehydrogenase 2 Family Member
First reported 1950
Supporting publications 65
Approved treatment annotated
Association Review

In brief

The association between ALDH2 (Aldehyde Dehydrogenase 2 Family Member) and Alcohol Dependence is supported by expert-curated evidence, supported by a single expert-curated source.

Sources 1
Clinical variants 1
Symptoms 3
Compounds 3
Trials 113of 427 via ALDH2 compounds
Publications 65
01
At a glance

Association overview

A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.

Request access
02
Provenance

Evidence and sources

1 source

Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.

Request access
03
ALDH2

The gene

2 source summaries

A gene summary alongside the source descriptions it was distilled from.

Request access
04
Alcohol Dependence

The disorder

7 database identifiers

The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).

Request access
05
Phenotype

Clinical features

1 clinical feature

The disorder’s clinical features (HPO) grouped by body system, each with observed frequency and penetrance.

Request access
06
ClinVar and variant evidence

Genetic basis

1 clinical variant

ClinVar variants reported for this pair, with disorder-specific significance, review status, molecular consequence and origin.

Request access
07
Population genetics

GWAS signals

2 GWAS phenotypes

Gene-associated GWAS phenotypes matching the disorder, with best SNP, score, risk-allele frequency and effect size.

Request access
08
Interventions

Therapeutics

3 compounds & drugs

Gene-targeting drugs and associated compounds, with class, approval status, mechanism, indications and trials.

Request access
09
Human studies

Clinical trials

427 clinical trials

Clinical trials reached through the pair’s compounds, keeping disorder-targeting trials separate from other indications.

Request access
10
Literature

Reading

65 publications

Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.

Request access
11
Provenance

References & sources

16 references

Every source and publication cited across this dossier, as one numbered reference list.

Request access